Illustration of the ultrastructure of the Covid-19 virus
CDC/SCIENCE PHOTO LIBRARY
Covid-19: two drugs against Sars-CoV-2 were designed and synthesized by the Wenhao Dai team, of the Chinese Academy of Sciences.
Sars-CoV-2 is the etiological agent responsible for the global COVID-19 outbreak.
The main protease (Mpro) of Sars-CoV-2 is a key enzyme that plays a pivotal role in mediating viral replication and transcription.
Scientists designed and synthesized two lead compounds (11a and 11b) targeting Mpro.
Both exhibited excellent inhibitory activity and potent anti-Sars-CoV-2 infection activity.
Both compounds showed good PK properties in vivo, and 11a also exhibited low toxicity, suggesting that these compounds are promising drug candidates.
See also:
Trial drug can significantly block early stages of COVID-19 in engineered human tissues (2020-04-10)
Link…
COVID-19, antimalarial drugs, malaria and blood type (2020-04-04)
Link…
Hydroxychloroquine and azithromycin as a treatment of COVID-19 (2020-03-18)
Link…
For more information
The link to the original article:
Science
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Link…
MDN
This post is also available in:
Italian
